Decreased bioavailability of NO is an important mechanism in both vascular inflammation and hypertension and impaired NO production may be a result of reduced eNOS activity, substrate/cofactor availability, presence of endogenous inhibitors and localization of eNOS. Here, NOS3 is linked to Hypertension.